The University of Chicago Header Logo

Adam DuVall

Concepts (99)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
9
2024
394
2.860
Why?
Insurance Claim Review
2
2023
45
1.110
Why?
Leukemia, Myeloid, Acute
8
2024
797
1.110
Why?
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
2
2023
54
1.040
Why?
Cancer Survivors
2
2022
95
0.860
Why?
Lymphoma, Mantle-Cell
1
2023
37
0.860
Why?
Lymphoma, T-Cell
1
2023
55
0.850
Why?
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
1
2023
51
0.850
Why?
Lymphoma
1
2023
265
0.780
Why?
Psychotherapy, Brief
1
2021
12
0.770
Why?
Neoplasms
4
2024
3079
0.680
Why?
Hematopoietic Stem Cell Transplantation
4
2024
891
0.530
Why?
Adolescent
7
2024
9288
0.410
Why?
Health Care Costs
2
2023
235
0.380
Why?
Tumor Suppressor Protein p53
5
2024
417
0.370
Why?
Humans
24
2024
89621
0.290
Why?
United States
4
2024
7020
0.280
Why?
Bridged Bicyclo Compounds, Heterocyclic
2
2024
90
0.280
Why?
Antineoplastic Combined Chemotherapy Protocols
5
2024
2567
0.260
Why?
Adult
10
2024
26694
0.260
Why?
Retrospective Studies
6
2024
9089
0.250
Why?
Sulfonamides
2
2024
319
0.240
Why?
CD47 Antigen
1
2024
23
0.230
Why?
Aniline Compounds
1
2023
59
0.220
Why?
Aminopyridines
1
2023
40
0.220
Why?
Triazines
1
2023
53
0.220
Why?
Pyrazines
1
2023
94
0.220
Why?
Survivors
2
2022
234
0.220
Why?
Mental Health
1
2024
178
0.210
Why?
Costs and Cost Analysis
1
2023
153
0.210
Why?
Blood Platelet Disorders
1
2022
10
0.210
Why?
Health Resources
1
2023
81
0.210
Why?
Primary Ovarian Insufficiency
1
2022
21
0.200
Why?
Young Adult
6
2024
6347
0.190
Why?
Lymphoma, B-Cell
1
2022
106
0.190
Why?
Socioeconomic Factors
1
2024
591
0.190
Why?
Patient Acceptance of Health Care
1
2023
261
0.190
Why?
Graft vs Host Disease
1
2023
360
0.180
Why?
Hematologic Neoplasms
1
2024
343
0.180
Why?
Acute Disease
1
2022
842
0.170
Why?
Self Report
1
2021
297
0.170
Why?
Female
9
2024
46354
0.160
Why?
Pilot Projects
1
2021
873
0.160
Why?
Mutation
3
2024
4162
0.160
Why?
Hyperbilirubinemia
1
2018
21
0.150
Why?
Carnitine
1
2018
14
0.150
Why?
Asparaginase
1
2018
35
0.150
Why?
Healthcare Disparities
1
2022
422
0.150
Why?
Hospitalization
1
2023
880
0.150
Why?
Immunotherapy
1
2023
689
0.150
Why?
Chemical and Drug Induced Liver Injury
1
2018
66
0.150
Why?
Male
7
2024
42558
0.150
Why?
Depression
1
2021
509
0.150
Why?
T-Lymphocytes
1
2023
1226
0.140
Why?
Quality of Life
1
2024
1673
0.130
Why?
Polyethylene Glycols
1
2018
359
0.130
Why?
Philadelphia Chromosome
2
2024
41
0.110
Why?
fms-Like Tyrosine Kinase 3
2
2023
131
0.110
Why?
Antineoplastic Agents
1
2023
2415
0.100
Why?
Transplantation, Homologous
2
2024
997
0.090
Why?
Drug Resistance, Neoplasm
2
2024
618
0.090
Why?
Aged
5
2024
19237
0.090
Why?
Protein Kinase Inhibitors
2
2024
605
0.080
Why?
Middle Aged
5
2024
26069
0.080
Why?
Neoplasm Recurrence, Local
2
2024
1366
0.070
Why?
Amenorrhea
1
2024
28
0.060
Why?
Menstruation
1
2024
35
0.060
Why?
Premenopause
1
2024
57
0.060
Why?
Menorrhagia
1
2024
26
0.060
Why?
Gonadotropin-Releasing Hormone
1
2024
108
0.060
Why?
Tranexamic Acid
1
2024
37
0.060
Why?
bcl-X Protein
1
2023
54
0.060
Why?
Allografts
1
2024
183
0.060
Why?
Myeloid Cell Leukemia Sequence 1 Protein
1
2023
37
0.060
Why?
Induction Chemotherapy
1
2024
152
0.060
Why?
Aged, 80 and over
2
2024
6834
0.060
Why?
Social Determinants of Health
1
2024
102
0.050
Why?
Retreatment
1
2022
108
0.050
Why?
Proto-Oncogene Proteins c-bcl-2
1
2023
196
0.050
Why?
Core Binding Factor Alpha 2 Subunit
1
2022
57
0.050
Why?
Myeloproliferative Disorders
1
2024
133
0.050
Why?
Salvage Therapy
1
2023
236
0.050
Why?
Germ Cells
1
2022
130
0.050
Why?
Myelodysplastic Syndromes
1
2024
359
0.050
Why?
Transcriptional Activation
1
2022
294
0.050
Why?
Transplantation Conditioning
1
2023
374
0.050
Why?
Enzyme Inhibitors
1
2023
645
0.050
Why?
Survival Rate
1
2024
1909
0.040
Why?
Treatment Outcome
2
2024
8273
0.040
Why?
Liver Function Tests
1
2018
92
0.040
Why?
Cell Line, Tumor
1
2023
2565
0.040
Why?
Apoptosis
1
2023
1720
0.030
Why?
Prognosis
1
2024
3796
0.030
Why?
Antibodies, Monoclonal, Humanized
1
2022
972
0.030
Why?
Remission Induction
1
2018
740
0.030
Why?
Ultrasonography
1
2018
712
0.030
Why?
Liver
1
2018
1210
0.030
Why?
Signal Transduction
1
2023
3393
0.030
Why?
Child
1
2018
7197
0.020
Why?
DuVall's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (99)
Explore
_
Co-Authors (28)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_